Univercells Technologies in tie-up with Chinese player on viral vectors for CGT and vaccine sectors
Belgium’s Univercells Technologies and China’s VectorBuilder have entered a strategic global partnership for custom viral vector production.
Archives for July 12, 2021
ReiThera’s COVID-19 vaccine looks to Phase 3 trial after preliminary Phase 2 data
Antibody responses against the SARS-CoV-2 spike protein were found in 99% of volunteers after the second dose of ReiThera’s COVID-19 vaccine candidate, according to Phase 2 preliminary data.
EMA finds possible link between mRNA COVID-19 vaccines and myocarditis & pericarditis
The safety committee of the European Medicines Agency (EMA) has concluded that myocarditis and pericarditis can occur in very rare cases following vaccination with the COVID-19 vaccines from Pfizer and Moderna.
FDA lead calls for independent inquiry into Biogen drug approval
Acting US FDA commissioner, Janet Woodcock, has called for an independent federal review of interactions between officials at her agency and representatives of Biogen, prior to the recent approval of the pharma company’s treatment for Alzheimer’s disease.